Ganesan Baranidharan
Leeds Teaching Hospitals NHS Trust
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Ganesan Baranidharan.
Pain Practice | 2015
Stefan Schu; Ashish Gulve; Sam Eldabe; Ganesan Baranidharan; Katharina Wolf; Walter Demmel; Dirk Rasche; Manohar Sharma; Daniel Klase; Gunnar Jahnichen; Anders Wahlstedt; Harold Nijhuis; Liong Liem
Spinal cord stimulation (SCS) is a standard treatment option for chronic neuropathic pain. However, some anatomical pain distributions are known to be difficult to cover with traditional SCS‐induced paresthesias and/or may also induce additional, unwanted stimulation. We present the results from a retrospective review of data from patients with groin pain of various etiologies treated using neuromodulation of the dorsal root ganglion (DRG).
Neuromodulation | 2013
Salma Mohammed; Sam Eldabe; Karen H. Simpson; Morag Brookes; Grace Madzinga; Ashish Gulve; Ganesan Baranidharan; Helen Radford; Tracey Crowther; Eric Buchser; Christophe Perruchoud; Alan M. Batterham
This study evaluated efficacy and safety of bolus doses of ziconotide (Prialt®, Eisai Limited, Hertfordshire, UK) to assess the option of continuous administration of this drug via an implanted intrathecal drug delivery system.
Therapeutic Advances in Neurological Disorders | 2013
Ganesan Baranidharan; Sangeeta Das; Arun Bhaskar
In the European Union, the high-concentration capsaicin patch is licensed for the management of neuropathic pain conditions in nondiabetic patients, including postherpetic neuralgia (PHN) and HIV-associated distal sensory polyneuropathy (HIV-DSP). However, in the USA, the Food and Drug Administration approved its use only in PHN patients. Capsaicin is a transient receptor potential vanilloid-1 agonist, which increases the intracellular calcium ion concentration. This triggers calcium-dependent protease enzymes causing cytoskeletal breakdown and leads to the loss of cellular integrity and ‘defunctionalization’ of nociceptor fibres. Efficacy and therapeutic effect has been shown in several clinical studies of PHN and HIV-DSP. The high-concentration capsaicin patch and its practical application are different from low-concentration creams; one application can help for up to 3 months. The process of setting up of a service to use the capsaicin 8% patch is also discussed.
Neuromodulation | 2017
Timothy R. Deer; David A. Provenzano; Michael Hanes; Jason E. Pope; Simon Thomson; Marc Russo; Tory McJunkin; Michael Saulino; Louis J. Raso; Shivanand P. Lad; Samer Narouze; Steven M. Falowski; Robert M. Levy; Ganesan Baranidharan; Stanley Golovac; Didier Demesmin; William O. Witt; Brian Simpson; Elliot S. Krames; Nagy Mekhail
The use of neurostimulation for pain has been an established therapy for many decades and is a major tool in the arsenal to treat neuropathic pain syndromes. Level I evidence has recently been presented to substantiate the therapy, but this is balanced against the risk of complications of an interventional technique.
Neuromodulation | 2015
Kristiaan Deckers; Kris De Smedt; Jean-Pierre Van Buyten; Iris Smet; Sam Eldabe; Ashish Gulve; Ganesan Baranidharan; José De Andrés; Christopher Gilligan; Kristen N. Jaax; Jan Pieter Heemels; Peter Crosby
Electrical stimulation for multifidus muscle contraction is a novel approach for treating chronic low back pain (CLBP). A multicenter, open‐label feasibility study investigated this modality in patients with continuing CLBP despite medical management and no prior back surgery and no known pathological cause of CLBP.
Neuromodulation | 2014
Ganesan Baranidharan; Karen H. Simpson; Karthikeyan Dhandapani
Spinal cord stimulation and dorsal column stimulation have been used successfully in the management of visceral pain for many years. A novel technique of ventral column stimulation has been used in our institute with good outcomes since 2007. We describe a retrospective series of 26 patients with visceral neuropathic pain who were treated with neuromodulation.Background Spinal cord stimulation and dorsal column stimulation have been used successfully in the management of visceral pain for many years. A novel technique of ventral column stimulation has been used in our institute with good outcomes since 2007. We describe a retrospective series of 26 patients with visceral neuropathic pain who were treated with neuromodulation. Methods Patients with either dermatomal hyperalgesia or sympathetically mediated neuropathic abdominal pain who had been treated with spinal cord stimulation were assessed. An independent observer conducted a face-to-face interview with each patient to collect data including demography, electrode placement, electrode mapping, and outcomes. Results There was significant reduction in visual analog pain scores from a median 9 at baseline to 4 at 26 months (p ≤ 0.05). Reduction in opioid consumption was very significant from a baseline median oral morphine equivalent of 160 mg to 26 mg (p < 0.001). In addition, quality of life, activities of daily living, and patient global impression of change improved. Conclusion There is a need to further investigate the use of ventral stimulation for visceral pain syndromes. This would need multicenter trials to collect adequate numbers of patients to allow hypothesis testing to underpin recommendations for future evidence-based therapies.
Neuromodulation | 2018
Kristiaan Deckers; Kris De Smedt; Bruce Mitchell; David Vivian; Marc Russo; Peter Georgius; Matthew Green; John Vieceli; Sam Eldabe; Ashish Gulve; Jean-Pierre Van Buyten; Iris Smet; Vivek A. Mehta; Shankar Ramaswamy; Ganesan Baranidharan; Richard Sullivan; Robert Gassin; James P. Rathmell; Christopher Gilligan
The purpose of the international multicenter prospective single arm clinical trial was to evaluate restorative neurostimulation eliciting episodic contraction of the lumbar multifidus for treatment of chronic mechanical low back pain (CMLBP) in patients who have failed conventional therapy and are not candidates for surgery or spinal cord stimulation (SCS).
Archive | 2012
Karen H. Simpson; Ganesan Baranidharan; Sanjeeva Gupta; Simon Tordoff
1. Applied anatomy and fluoroscopy for spinal interventions 2. Imaging in pain medicine 3. Drugs, equipment and basic principles of spinal interventions 4. Lumbar spine interventions 5. Cervical spine interventions 6. Thoracic spine interventions 7. Disc interventions 8. Vertebroplasty and kyphoplasty 9. Spinal cord stimulation in the treatment of chronic pain 10. Intrathecal drug delivery (ITDD) 11. Autonomic blocks 12. Spinal interventions for cancer pain 13. Head and neck interventions 14. Medicolegal issues and interventional pain management
Journal of Disability and Religion | 2016
Jill Edwards; Michelle Briggs; S. José Closs; Karl Atkin; Michael I. Bennett; Chris Swift; Ganesan Baranidharan
ABSTRACT Self-management forms an essential part of the management of chronic pain. It affects approximately 7.8 million people in the United Kingdom, with older people more likely to live with chronic pain. In the United Kingdom, the National Health Service is committed to providing patient-centered care, which embraces the religious and spiritual needs of patients. This aspect of care is governed by uncertainty; there is a lack of understanding about the influence of religious faith on illness and no clear guidance on how faith needs are best addressed. This study explored the interrelationships between chronic pain and religious faith among older people.
Neuromodulation | 2018
Timothy R. Deer; Jason E. Pope; Tim J. Lamer; Jay S. Grider; David A. Provenzano; Timothy R. Lubenow; James J. FitzGerald; Corey Hunter; Steven M. Falowski; Dawood Sayed; Ganesan Baranidharan; Nikunj K. Patel; Timothy Davis; Alexander L. Green; Antonio Pajuelo; Lawrence J. Epstein; Michael E. Harned; Liong Liem; Paul J. Christo; Krishnan Chakravarthy; Christopher A. Gilmore; Frank Huygen; Eric T. Lee; Pankaj Metha; Harold Nijhuis; Denis G. Patterson; Erika A. Petersen; Julie G. Pilitsis; Jeffery Rowe; Matthew P. Rupert
The Neuromodulation Appropriateness Consensus Committee (NACC) is dedicated to improving the safety and efficacy of neuromodulation and thus improving the lives of patients undergoing neuromodulation therapies. With continued innovations in neuromodulation comes the need for evolving reviews of best practices. Dorsal root ganglion (DRG) stimulation has significantly improved the treatment of complex regional pain syndrome (CRPS), among other conditions. Through funding and organizational leadership by the International Neuromodulation Society (INS), the NACC reconvened to develop the best practices consensus document for the selection, implantation and use of DRG stimulation for the treatment of chronic pain syndromes.